Search

Your search keyword '"Blaison, Gilles"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Blaison, Gilles" Remove constraint Author: "Blaison, Gilles"
139 results on '"Blaison, Gilles"'

Search Results

1. Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort

2. French protocol for the diagnosis and management of systemic lupus erythematosus

3. Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases

4. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

5. Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)

6. Identification of Key Predictors of Cryoglobulinemia Severity at Diagnosis: Threshold, Type, and Severity Score at Diagnosis.

7. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

8. Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases

9. LBP2 Development and validation of a patient-centered autoevaluation questionnaire in systemic lupus erythematosus: LUPIN

10. Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature

11. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus

12. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

13. Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus.

14. Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome

16. The mediating effect of fatigue in impaired quality of life in systemic lupus erythematosus: mediation analysis of the French EQUAL cohort.

18. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus

20. The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)

21. Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study

22. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome

23. Prevalence of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture–Recapture and Geospatial Analysis

24. Prevalence of antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis and spatial association with quarries in a French Northeast region

26. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

27. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

28. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

30. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study

31. Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

32. Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus

33. Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations

34. Association of antiphospholipid antibodies with active digital ulceration in systemic sclerosis

36. Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus.

38. Factors Associated with Specific Quality of Life Evolution in SLE Patients: A French Prospective Longitudinal Multicenter Study

39. Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients

40. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors

41. Ce qu'il faut savoir sur les cryoglobulines en 2020.

42. Disease-specific quality of life following a flare in systemic lupus erythematosus: an item response theory analysis of the French EQUAL cohort.

43. Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature

46. Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature.

47. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

48. Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast Region

49. Intérêt d'un dépistage chez les apparentés asymptomatiques d'un cas-index porteur d'une thrombophilie héréditaire symptomatique.

50. Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome

Catalog

Books, media, physical & digital resources